Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer

BACKGROUND: Endocrine therapies are the mainstay of treatment for oestrogen receptor (ER)-positive (ER(+)) breast cancer (BC). However, resistance remains problematic largely due to enhanced cross-talk between ER and growth factor pathways, circumventing the need for steroid hormones. Previously, we...

全面介紹

Na minha lista:
書目詳細資料
發表在:Breast Cancer Res
Main Authors: Ribas, Ricardo, Pancholi, Sunil, Rani, Aradhana, Schuster, Eugene, Guest, Stephanie K., Nikitorowicz-Buniak, Joanna, Simigdala, Nikiana, Thornhill, Allan, Avogadri-Connors, Francesca, Cutler, Richard E., Lalani, Alshad S., Dowsett, Mitch, Johnston, Stephen R., Martin, Lesley-Ann
格式: Artigo
語言:Inglês
出版: BioMed Central 2018
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992820/
https://ncbi.nlm.nih.gov/pubmed/29880014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-018-0983-1
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍